MTOR and neoplasm: Immunohistochemical analysis of 3D heterotypic tumor spheroids confirmed that both individual and combined treatment with TAS-115 and DOXO reduced the expression of c-MET, p–c-MET, and p-mTOR, a key node in the PI3K/Akt/mTOR pathway.